It's easy to forget the staggering triumphs we've achieved with so many problems in the world today... For example, we lived with smallpox for 10,000 years...........
Daily Wealth

Dear Null,

With so many problems in the world – it's easy to forget the staggering triumphs we've achieved.

For example, we lived with smallpox for 10,000 years.

In the 20th Century alone, it killed an estimated 500 million people.

And then, suddenly, it was GONE.

On May 8, 1980, the World Health Assembly accepted this letter from an international commission– declaring smallpox eradicated form planet Earth:

From 500M deaths to ZERO. (This killer is next.)

Heart disease deaths have fallen 75% since the 1950s.

Now, the same kind of thing is happening with cancer.

I know it may be hard to believe. Cancer is so painful. So destructive.

I doubt there's any one of us that hasn't been affected in some way.

But it really is time to stop talking about "treatments" or "therapies" and start talking about a cure.

Here's why.

Right now, very few people in the world know about the research in this presentation.

You'll be among the first. Most importantly, I hope it means you can help someone you care about in a time of need.

It also means you can get in on the ground floor of a $5 trillion opportunity: A real, science-based cure for cancer.

For investors, the gains could be staggering.

And to celebrate this triumph, we're doing something we've NEVER done in 20 years at Stansberry Research, for a short time.

Regards,

Steven Longenecker
Senior Editor, Stansberry Research

P.S. For decades, the word "cure" has been abused by folks who were either badly misinformed... or trying to take advantage of people in the worst moments of their lives. It's disgraceful.

What's happening now is very different. I just saw it with my own eyes at a conference of 11,000 cancer researchers and highly-paid oncologists. See the discovery here.



All contents of this e-mail are copyright 2019 by Stansberry Research. All rights reserved. Reproducing any part of this document is prohibited without the express written consent of Porter Stansberry. Protected by U.S. Copyright Law {Title 17 U.S.C. Section 101 et seq., Title 18 U.S.C. Section 2319}: Infringements can be punishable by up to five years in prison and $250,000 in fines.

DISCLAIMER: The work included in this publication is based on SEC filings, current events, interviews, and corporate press releases. It may contain errors, and you shouldn't make any investment decision based solely on what you read here. It's your money and your responsibility. The views expressed in this publication do not necessarily reflect the views of Stansberry Research.

You're receiving this email at newsletter@newslettercollector.com. If you have any questions about your subscription, or would like to change your email settings, please contact Stansberry Research at (888) 261-2693 Monday-Friday between 9:00 a.m. and 5:00 p.m. Eastern Time. Or if calling internationally, please call 443-839-0986. Stansberry Research, 1125 N Charles Street Baltimore, MD 21201. If you wish to contact us by email, please do not reply to this message but instead go to info@stansberrycustomerservice.com.

To unsubscribe from this mailing, click here: Unsubscribe